Sotera Health Co. (SHC) intrinsic value & 10-year financials
Sotera Health Co. (SHC) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 8 fiscal years revenue grew 6.9% a year to $1.2B, with an average return on invested capital of 7.2%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $17.89
- Market cap
- $5.1B
- Revenue (FY2025)
- $1.2B
- Revenue growth (8-yr CAGR)
- 6.9%
- ROIC (10-yr avg)
- 7.2%
- Free cash flow (FY2025)
- $149.2M
SHC 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.2B | $77.9M | $0.27 | $149.2M | — | 3.1% |
| FY2024 | $1.1B | $44.4M | $0.16 | $45.1M | 27.0% | 6.0% |
| FY2023 | $1.0B | $51.4M | $0.18 | -$362.7M | 26.4% | 6.2% |
| FY2022 | $1.0B | -$233.6M | -$0.83 | $95.6M | 24.7% | 11.2% |
| FY2021 | $931.5M | $116.9M | $0.41 | $179.4M | 27.6% | 7.5% |
| FY2020 | $818.2M | -$38.6M | -$0.16 | $67.1M | 25.2% | 8.8% |
| FY2019 | $778.3M | -$20.9M | -$0.09 | $91.8M | 23.6% | — |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Sotera Health Co revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Sotera Health Co has historically struggled to out-earn its cost of capital, averaging just 7.2% ROIC.
Sotera Health Co capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Sotera Health Co is modeled at -9.9% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-2.64 per share.